Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.18 USD | +2.83% | -9.10% | +66.18% |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.18% | 169.8Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.05% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Edgewise Therapeutics : SVB Leerink Starts Edgewise Therapeutics at Outperform With $34 Price Target